ClinicalTrials.gg
CompletedNCT03318692Updated May 31, 2024

Patient Specific Template Guided Pedicle Instrumentation Versus Free Hand Technique

An interventional study of spondylodesis and CT in Spinal Cord Diseases, sponsored by Balgrist University Hospital. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-31.

Sponsored by Balgrist University Hospital · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The clinically already tested and approved MySpine system is compared to the free-hand dorsal instrumentation, which is the gold standard in spondylodesis surgery. The aim of this study is to investigate whether or not the pedicle screw can be inserted anatomically more accurately by the MySpine system than by the conventional free-hand method using intraoperative fluoroscopy.

Read the detailed description

Patients with an indication for spondylodesis are included according to the inclusion criteria and exclusion criteria. Subsequently, randomization into the MySpine and conventional group is performed. Patients remain blinded to the randomization.

On the basis of a computed tomography, the surgeon plans the entry points, the screw size and length, as well as the angle of the screws in two planes (sagittal and axial) on the computer. In the MySpine group, a three-dimensional, digital reconstruction of the spine is made using Medacta International SA software. On the basis of these planning files, three-dimensional templates with guide channels (guides) are produced for each individual vertebra. These guides can be applied dorsally to the bony anatomy and thus specify the entry points as well as the direction of the screw. Also, replicas of the individual vertebra are produced in the 3D printer.

The patients are operated in a prone position via a dorsal approach. After preparation of the dorsal process, vertebral arches and vertebral joints as well as the transverse process, the screws are implanted with one of the following methods depending on the randomization:

  1. Freehand (fluoroscopically controlled)
  2. MySpine System

Postoperatively, all patients undergo computed tomography of the operated area. On the basis of this computed tomography the number of pedicle perforations as well as their extent should be determined according to the simplified Laine classification. These results are to be statistically evaluated with the question of whether there are significant differences between the two techniques with respect to the absolute and individual number of pedicle perforations, as well as their extent. It is also to be examined whether these results show a dependence on the level of experience of the surgeon.

In addition to the individual radiation exposure (cumulative irradiation time in seconds and irradiation dose in cGy), the time for the dorsal instrumentation for each of the two systems per surgeon is also to be measured and evaluated.

In the follow-up, the outcome is also recorded by means of pain registration, ODI score and complication detection (infections, pedicle fractures, implant loosening, pseudoarthrosis, re-operations).

The follow-up assessments 6 weeks, 6 months, 1 year and 2 years after surgrey are peformed according to institutional standards.

02

Conditions studied

  • Spinal Cord Diseases

Browse trials for

03

In context

Spinal Cord Diseases

170 studies on the registry are indexed under Spinal Cord Diseases; 56 are open to participants now.

This study's enrollment of 66 is above the median of 36 across 120 interventional studies indexed under Spinal Cord Diseases.

Browse Spinal Cord Diseases studies →

Lead sponsor

Balgrist University Hospital is the lead sponsor of 81 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Indication for spondylodesis independent of the study
  • Signed consent
  • Male and female patients aged 18 years and over

Exclusion criteria

Exclusion Criteria:

  • Polyamide-PA 12 allergy
  • Pregnant or lactating women
  • Known or suspected non-compliance with the protocol, drug or alcohol abuse
  • inability of the patient to follow the trial procedure, e.g. Due to language problems, mental illness, dementia
  • Prior participation in the clinical Trial
  • Inclusion of the test person, his / her family members, employees or other dependent persons
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    MySpine System

    pedicle screw implantation (spondylodesis) using the MySpine System. post surgery CT.

    Procedure: spondylodesis · Procedure: CT

  • Active comparator
    free-hand

    Freehand (fluoroscopically controlled) implantation of pedicle screw (spondylodesis). Post surgery CT

    Procedure: spondylodesis · Procedure: CT

Interventions

  • Procedurespondylodesis

    Dorsal instrumentation with transpedicular screws (spondylodesis)

  • ProcedureCT

    CT of operated area is performed within 7 days of surgery

06

What researchers measure

Primary outcomes

  1. accuracy

    Anatomical accuracy of pedicle screw implantation (intactness of the pediculate cortex in 3 planes), postoperatively measured via computertomographically existing or nonexisting pedicle perforation and their extent according to the simplified Laine classification: Grade A (\<2 mm), Grade B (2-4 mm) and Grade C (\> 4 mm)

    Time frame: within 7 days post surgery

Secondary outcomes

  1. duration

    Intraoperative time spent on dorsal Instrumentation is documented and compared between the groups

    Time frame: during surgery

  2. Radiation exposure

    cummulative Radiation exposure during surgery is measured and compared between the groups

    Time frame: during surgery

  3. blood loss

    blood loss during surgery is documented and compared between the groups

    Time frame: during surgery

  4. complications

    intraoperative and post-operative complications such as pedicle fractures, implant loosening, infections and pseudo arthrosis are documented and compared between the groups

    Time frame: during surgery until end of follow up (24 months after surgery)

  5. reoperations

    reoperations are documented and compared between the groups

    Time frame: until end of follow up (24 months after surgery)

07

Study locations

1 site
  • Balgrist University Hospital
    Zürich, Zurich 8008, Switzerland
08

References and documents

Individual participant data

Plan to share: No — IPD only available to study personnel. statistical Analysis will be done with encoded data only. study results will be published

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2017 to primary completion in Mar 2024, 81 months.

Of 54 non-industry interventional studies with no phase under Spinal Cord Diseases, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 81. This study's 81 months is above that.

Counting every sponsor, half of 58 studies reached it within 48 months; a quarter within 20 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2017
First posted
Oct 24, 2017
StartActual
Jun 23, 2017
Primary completionActual
Mar 30, 2024
CompletionActual
Mar 31, 2024
Last update
May 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03318692
Lead sponsor
Balgrist University Hospital
Responsible party
Sponsor
First posted
Oct 24, 2017
Start date
Jun 23, 2017
Primary completion
Mar 30, 2024
Completion
Mar 31, 2024
Last update
May 31, 2024

Study contacts

Mazda Farshad, Prof. Dr.med.
principal investigator · Balgrist University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion